These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 24655801

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base.
    Mikell JL, Gillespie TW, Hall WA, Nickleach DC, Liu Y, Lipscomb J, Ramalingam SS, Rajpara RS, Force SD, Fernandez FG, Owonikoko TK, Pillai RN, Khuri FR, Curran WJ, Higgins KA.
    J Thorac Oncol; 2015 Mar; 10(3):462-71. PubMed ID: 25384064
    [Abstract] [Full Text] [Related]

  • 3. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.
    Matsuguma H, Nakahara R, Ishikawa Y, Suzuki H, Inoue K, Katano S, Yokoi K.
    Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):573-7. PubMed ID: 18413349
    [Abstract] [Full Text] [Related]

  • 4. Mediastinal downstaging after induction treatment is not a significant prognostic factor to select patients who would benefit from surgery: the clinical value of the lymph node ratio.
    Renaud S, Falcoz PE, Olland A, Reeb J, Santelmo N, Massard G.
    Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):222-7. PubMed ID: 25413781
    [Abstract] [Full Text] [Related]

  • 5. Role of postoperative radiotherapy after curative resection and adjuvant chemotherapy for patients with pathological stage N2 non-small-cell lung cancer: a propensity score matching analysis.
    Kim BH, Kim HJ, Wu HG, Kang CH, Kim YT, Lee SH, Kim DW.
    Clin Lung Cancer; 2014 Sep; 15(5):356-64. PubMed ID: 24996882
    [Abstract] [Full Text] [Related]

  • 6. Adjuvant radiotherapy and lymph node dissection in pancreatic cancer treated with surgery and chemotherapy.
    Mellon EA, Springett GM, Hoffe SE, Hodul P, Malafa MP, Meredith KL, Fulp WJ, Zhao X, Shridhar R.
    Cancer; 2014 Apr 15; 120(8):1171-7. PubMed ID: 24390779
    [Abstract] [Full Text] [Related]

  • 7. [Outcomes and the role of adjuvant therapy of limited stage small cell lung cancer undergoing surgical treatment].
    Yu J, Ouyang W, Huang Z, Chen G, Zhou Y, Mao YL, Zhang JH, Xie CH.
    Zhonghua Zhong Liu Za Zhi; 2020 Apr 23; 42(4):336-339. PubMed ID: 32375451
    [Abstract] [Full Text] [Related]

  • 8. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P, Herndon J, Langer M, Kohman LJ, Elias AD, Kass FC, Eaton WL, Seagren SL, Green MR, Sugarbaker DJ.
    Cancer; 1996 Jun 01; 77(11):2393-9. PubMed ID: 8635112
    [Abstract] [Full Text] [Related]

  • 9. Postoperative radiotherapy is effective in improving survival of patients with stage pIII-N2 non-small-cell lung Cancer after pneumonectomy.
    Wang W, Men Y, Wang J, Zhou Z, Chen D, Xiao Z, Feng Q, Lv J, Liang J, Bi N, Gao S, Wang L, Hui Z.
    BMC Cancer; 2019 May 22; 19(1):478. PubMed ID: 31113432
    [Abstract] [Full Text] [Related]

  • 10. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
    Kang CH, Ra YJ, Kim YT, Jheon SH, Sung SW, Kim JH.
    Ann Thorac Surg; 2008 Oct 22; 86(4):1092-7. PubMed ID: 18805138
    [Abstract] [Full Text] [Related]

  • 11. The role of postoperative radiotherapy (PORT) in combined small cell lung cancer (C-SCLC).
    Men Y, Luo Y, Zhai Y, Liang J, Feng Q, Chen D, Xiao Z, Zhou Z, Hui Z, Wang L.
    Oncotarget; 2017 Jul 25; 8(30):48922-48929. PubMed ID: 28430661
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prognostic Impact of Node-Spreading Pattern in Surgically Treated Small-Cell Lung Cancer: A Multicentric Analysis.
    Leuzzi G, Lococo F, Alessandrini G, Sperduti I, Spaggiari L, Venuta F, Rendina EA, Granone PM, Rapicetta C, Zannini P, Di Rienzo G, Nicolosi M, Facciolo F.
    Lung; 2017 Feb 25; 195(1):107-114. PubMed ID: 27738827
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nodal stage of surgically resected non-small cell lung cancer and its effect on recurrence patterns and overall survival.
    Varlotto JM, Yao AN, DeCamp MM, Ramakrishna S, Recht A, Flickinger J, Andrei A, Reed MF, Toth JW, Fizgerald TJ, Higgins K, Zheng X, Shelkey J, Medford-Davis LN, Belani C, Kelsey CR.
    Int J Radiat Oncol Biol Phys; 2015 Mar 15; 91(4):765-73. PubMed ID: 25752390
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the efficacy of radiotherapy between postoperative mediastinal lymph node recurrence and stage III disease in non-small cell lung cancer patients.
    Imai H, Murakami H, Yoshino R, Mori K, Sumita K, Ono A, Akamatsu H, Taira T, Kenmotsu H, Harada H, Naito T, Kaira K, Tomizawa Y, Ohde Y, Matsuura M, Endo M, Saito R, Nakajima T, Takahashi T.
    J BUON; 2016 Mar 15; 21(2):333-40. PubMed ID: 27273942
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.